InterventionsHuman trialPreprint1,270 participantsRandomised trialDouble-blindPlacebo-controlledIndependent replicationRegistered NCT01038583
Aspirin and healthy longevity within racial and ethnic minoritized older adults in the United States
medRxiv
Abstract
ImportanceThe ASPREE randomized trial found no overall benefit of low-dose aspirin for disability-free survival among older adults. However, individual estimates in pre-specified subgroups indicated potential benefit among racial and ethnic minoritized participants in the United States (US).
The paper
George N. Tzimas, Joseph C Vanghelof, Aseel Mohammed, Raj C. Shah
Show 10 more authors
Daniela Stan Raicu, Lianlian Du, Michael E. Ernst, Erica T. Warner, Andrew Tan Chan, Joanne L. Ryan, Sara E Espinoza, Anne M. Murray, Kerry M. Sheets, Roselyne Tchoua,DePaul University · Rush University Medical Center
medRxiv · 31 Aug 2026 · CC BY · Preprint, not peer-reviewed
